| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.12▲ | 1.12▲ | 1.12▲ | 1.13▼ | 1.21▼ |
| MA10 | 1.14▲ | 1.14▼ | 1.15▼ | 1.14▼ | 1.23▼ |
| MA20 | 1.15▼ | 1.15▼ | 1.15▼ | 1.22▼ | 1.24▼ |
| MA50 | 1.14▼ | 1.13▲ | 1.15▼ | 1.26▼ | 0.96▲ |
| MA100 | 1.13▲ | 1.19▼ | 1.22▼ | 1.34▼ | 1.36▼ |
| MA200 | 1.20▼ | 1.26▼ | 1.27▼ | 1.09▲ | 6.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.005▼ | -0.003▼ | -0.009▼ | -0.049▼ |
| RSI | 48.531▼ | 49.069▼ | 49.222▼ | 38.467▼ | 47.373▼ |
| STOCH | 16.118▼ | 16.118▼ | 18.360▼ | 36.576 | 44.742 |
| WILL %R | -57.895 | -57.895 | -57.895 | -78.571▼ | -76.744▼ |
| CCI | -16.026 | -33.284 | -34.091 | -66.351 | -51.951 |
|
Wednesday, November 12, 2025 02:05 PM
Regains NYSE Compliance, Advances Toward First Clinical Trial And Expands AI-Driven Neurology Pipeline. Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing ...
|
|
Wednesday, November 12, 2025 05:41 AM
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today reported key operational, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.09 | 1.15 | 1.09 | 1.12 | 16,270 |
| 13/11/25 | 1.22 | 1.22 | 1.11 | 1.14 | 31,491 |
| 12/11/25 | 1.16 | 1.20 | 1.1501 | 1.16 | 35,058 |
| 11/11/25 | 1.1392 | 1.1502 | 1.1201 | 1.13 | 16,831 |
| 10/11/25 | 1.08 | 1.15 | 1.08 | 1.12 | 25,115 |
| 07/11/25 | 1.0863 | 1.12 | 1.06 | 1.1173 | 67,989 |
| 06/11/25 | 1.135 | 1.135 | 1.08 | 1.1003 | 46,726 |
| 05/11/25 | 1.14 | 1.16 | 1.132 | 1.14 | 18,548 |
| 04/11/25 | 1.195 | 1.195 | 1.11 | 1.13 | 54,850 |
| 03/11/25 | 1.22 | 1.22 | 1.1913 | 1.22 | 43,046 |
|
|
||||
|
|
||||
|
|